Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19
STOP-Coronavirus: Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19
Sponsor: Fundacion Investigacion Biomedica Hospital 12 de Octubre
This observational or N/A phase trial investigates Covid19 and is currently ongoing. Fundacion Investigacion Biomedica Hospital 12 de Octubre leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Oct 2022 — Jul 2024 [monthly]
Unknown Status
Status: Enrolling By Invitation → Unknown Status
-
Dec 2021 — Oct 2022 [monthly]
Enrolling By Invitation
-
Oct 2021 — Dec 2021 [monthly]
Enrolling By Invitation
▶ Show 3 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Enrolling By Invitation
-
Nov 2020 — Jan 2021 [monthly]
Enrolling By Invitation
-
Sep 2020 — Nov 2020 [monthly]
Enrolling By Invitation
First recorded
Aug 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundacion Investigacion Biomedica Hospital 12 de Octubre
- Hospital Universitario 12 de Octubre
- Hospital Universitario Fundación Jiménez Díaz
- Hospital Universitario Infanta Elena
- Hospital Universitario Virgen de la Arrixaca
- Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
For direct contact, visit the study record on ClinicalTrials.gov .